Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04541563 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT04541563 · ClinicalTrials.gov record · last posted 2021-02-11

Fisher Wallace Neurostimulation & Depression Study

StatusActive, Not Recruiting
PhaseNot applicable
SponsorProofPilot
Started2020-08-24
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 11, 2021 (before its estimated March 30, 2021 completion). Its status may not reflect the trial's current state.
from the ClinicalTrials.gov record
Examine the safety and effectiveness of the Fisher Wallace Cranial Electrotherapy Stimulator Device on Major Depressive Disorder using two 20-minute per day treatment sessions over eight weeks.

Amendment record 2 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 2 times since 2020-09-01; most recent amendment 2022-07-29. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2022-07-29
Status change Active, Not Recruiting→Completedv2
2021-02-09
Status change Recruiting→Active, Not Recruitingv1
Trial Details
NCT Number NCT04541563
Lead Sponsor ProofPilot
Collaborators: Fisher Wallace
Conditions Major Depressive Disorder
Enrollment 175 participants
Start Date 2020-08-24
Primary Completion 2021-03-30 (estimated)
Study Completion 2021-11-30 (estimated)
Updated on ClinicalTrials.gov 2021-02-11